Apertus Pharmaceuticals

About:

Apertus Pharmaceuticals is an API manufacturing company that provides controlled and non-controlled substance APIs.

Website: http://www.apertuspharma.com

Top Investors: BioGenerator

Description:

Apertus Pharmaceuticals is an Active Pharmaceutical Ingredient, or API, manufacturing company targeting dosage form manufacturing companies within the pharmaceutical industry. Apertus Pharmaceuticals provides controlled substance APIs, non controlled substance APIs, and intellectual property to the pharmaceutical market. In addition, Apertus Pharmaceuticals utilizes the philosophies of Green Chemistry as outlined by the FDA and will target higher purity standards than those set by the current standard setting authorities. Apertus is led by CEO Rick Ryan, Ph.D. and CSO David Gindelberger, Ph.D.

Total Funding Amount:

$700000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)apertuspharma.com

Founders:

David Gindelberger, Rick Ryan

Number of Employees:

1-10

Last Funding Date:

2012-01-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai